Partner Event: 30th Edition Portfolio Decision-Making & Prioritisation for Pharma
Wed 23 Sept
|Frankfurt am Main
Strengthen portfolio prioritisation and capital allocation strategies to navigate patent cliffs, rising R&D costs, and evolving decision frameworks
Time & Location
23 Sept 2026, 09:00 CEST – 25 Sept 2026, 16:30 CEST
Frankfurt am Main, Frankfurt am Main, Germany
About the event
The Marcus Evans 30th Edition Portfolio Decision-Making & Prioritisation for Pharma conference taking place on 23-25 September, 2026, in Frankfurt, Germany, will bring together senior leaders across portfolio management, PMO, R&D strategy, and commercial functions to explore how pharmaceutical organisations can make faster, and more robust portfolio investment decisions in a capital-constrained environment. Sessions will explore asset prioritisation under patent cliff pressure, portfolio governance and decision frameworks, reprioritisation strategies, and the integration of AI-enabled analytics to support more disciplined portfolio management. The agenda will also deliver actionable insights on managing portfolio trade-offs, overcoming governance bottlenecks, and aligning portfolio investments with long-term strategic objectives, helping pharmaceutical organisations improve decision speed, capital allocation discipline, and portfolio performance across complex and regulated development pipelines.
Attending This Premier Marcus Evans Conference Will Enable You to:
• Prioritise assets under funding pressure and patent cliff exposure
• Strengthen value realisation discipline after portfolio approval